9th Alzheimer Symposium and 3rd Nordic Memory Clinic Conference – NMCC, Kuopio, Finland, August 23-25, 2022
From genetics to personalized medicine, biomarkers, prevention, and therapies in Alzheimer’s disease and other neurodegenerative diseases
We are delighted to inform that we are organizing the 9th Alzheimer Symposium on August 23-25, 2022 in Kuopio, Finland together with the 3rd Nordic Memory Clinic Conference – NMCC.
The first Kuopio Alzheimer’s Disease Symposium was organized in 1999 and the last one in 2018. Each Kuopio Alzheimer Symposium has had a very interesting and rich program, and the speakers have been internationally acknowledged and respected leading experts on dementia research and care. The Kuopio Alzheimer Symposia have attracted every time on average 300 participants, who are PhD or MD-level researchers, clinicians, health care personnel, and students from Finland, other Nordic countries, and around the world. The symposium programs have been highly appreciated by the attendees.
This time, we are expecting an even higher number of congress participants to Kuopio since the 9th Alzheimer Symposium will be organized in parallel with the 3rd Nordic Memory Clinic Conference.
More detailed information: https://blogs2.uef.fi/kuopioadsymposium/
12th VERT Forum
March 24th 2022 (online)
Registration is required for participating in this ZOOM conference
Please use the following link:
because of the worldwide continuing threat by the COVID-19 pandemic the VERT Board made the decision in alignment with EMPA to organize this 12th VERT Forum online using the ZOOM format, which proved to be quite useful last time. The VERT Forum is an international meeting and we are expecting many guests and speakers from other countries for whom we feel responsible for safety and health during this event, so we had to come to this decision although we will deeply miss the chances for discussion, communication and networking.
This time we will focus on
- Health effects by UFP – new findings and the need for tighter emission limits
- Emission quality of combustion engines as expected with Euro 7/VII
- Best practice in large cities to clean the breathing air from in-use fleet emissions
- VERT research projects and latest findings
- Technical control NPTI by PN at idle for Diesel and Petrol vehicles worldwide – except USA.
- Better particle filters for petrol engine first fit and retrofit
- Trends and solutions for engines < 19 kW and > 560 kW
- Bioaerosols and how to eliminate them based on the existing nanofiltration principles
- UFP from brake wear and tire wear
Your will receive the final agenda by end of January.
Here is your Registration Link: Registration-12th-VERT-FORUM
Live webinar on ‘Endocrine disruption as a mechanism of developmental neurotoxicity (DNT)’
Date: 15.9.2021 Registration
Neurodegeneration beyond Amyloid and Tau
Organizing unit: A.I. Virtanen Institute for Molecular Sciences at the University of Eastern Finland (UEF)
Event start date: 10.6.2021, 8:45
Event end date: 11.6.2021, 14:30
Event location: Online/Kuopio campus
Registration by 20.5.2021 via this link:
This course will introduce the participants to emerging research topics in neurodegeneration in multiple disciplines. The course is directed at early career researchers who work or plan to work in the research fields including clinical research, neurobiology, epidemiology, translational research, and public health science. The lectures will be given by a panel of international and local experts on their current research on neurodegeneration, expanding current understanding of neurodegeneration related to amyloid and tau. Topics include defective homeostasis and the involvement of glia, genetic risk factors and biomarker discovery, environmental impact and lifestyle factors, translational research, and public health. The optional lab demonstration will focus on various methodologies of co-cultures in brain cells. If the COVID-19 situation allows, a maximum of 15 participants can attend the lab demonstration. The first 15 registered students that wish to attend the demonstration will be chosen.
Registrations by 20 May, 2021. Link to participation will be sent to all registered by email. Attendance virtually is free for all. External participants that are physically present the fee is € 30. If the COVID-19 situation allows, a maximum of 20 participants can attend at the venue. The first 20 registered participants can come.
Course director: Katja Kanninen
Day 1, 10 June
9.00-9.15 Opening remarks by Scientific Organizer
Session: Defective homeostasis and the involvement of glia
9.15-9.45 Microglia, Tony White, QIMR Berghofer, Australia
9.45-10.15 Astrocytes, Julia TCW, MSSM, USA
10.15-10.45 Autophagy/oxidative stress, Antonio Cuadrado, Spain
10.45-11.00 Short talk by early career researcher
11.00-11.20 Short break
Session: Genetic risk factors and biomarker discovery
11.20-11.50 Genetic risk factors, Mikko Hiltunen, UEF
11.50-12-20 Using biomarkers to optimise health systems for precision medicine, Simcha Jong Kon Chin, UEF, Leiden Uni
12.20-12.50 TBD, Anne Koivisto, UEF, KUH, UH, HUS
12.50-13.05 Short talk by early career researcher
Session: Environmental impact and lifestyle factors
14.00-14.30 Epidemiology: Betula study, Anna Oudin, Sweden
14.30-15.00 Diet and Dementia, Alina Solomon, UEF
15-15.30 Mens sana in corpore sano: lifestyle changes modify astrocytes to prolong cognitive longevity, Alexej Verkhratsky, U.K.
15.30-15.45 Short talk by early career researcher
15:45-16.00 Short break
16.00-16.30 Parallel sessions: pitch talks
Day 2, 11 June
9.00-9.15 Opening remarks
Session: Translational research in neuroscience
9.15-9.45 Discovery: in vitro, Andras Dinnyes, BioTalentum Ltd
9.45-10.15 Translational Neuroscience, Antti Nurmi, Charles River Laboratories
10.15-10.30 Short talk by early career researcher
10.30-10.50 Short break
Session: Public Health
10.50-11.20 Government, Public and Patient Involvement, Jean Georges, Alzheimer Europe
11.20-11.50 Health economic and quality of life impacts of early Alzheimer’s disease, Janne Martikainen, UEF
11.50-12.00 Closing remarks by Scientific Organizer
13.00-14.30 Lab demonstration
For further information, please contact: Katja Kanninen, email@example.com,
Riikka Lampinen, firstname.lastname@example.org or Sweelin Chew, email@example.com.
Students at the University of Eastern Finland
Credit points: 1-2 (1 for attendance at the lectures both days, 2 for attendance at the lectures both days and selected for short talk/pitch talk, or 2 for attendance at the lectures both days and attendance at lab demonstration).
Air Quality and Climate Online meeting: 18 May 2021 2 p.m. – 5 p.m. Central European Time
Meeting Organization Information
Due to the pandemic situation and its impact on planning and scheduling of conferences and gatherings in 2021 the traditional Ultrafine Particles Symposium, held in Brussels every second year, will be postponed to 2022. But to maintain the scientific and societal contact and exchange on that issue a very condensed three-hours online meeting of the community will be organized free of charge. Meanwhile all around the globe there is now enough experience with digital tools for teaching and conferencing. Nevertheless, this online meeting 2021 does not replace the Symposium in presence.
Chairman of the Meeting: Thomas Leisner, KIT Need more information, please contact: firstname.lastname@example.org
Ultrafine particles, (UFP), are the smallest constituents of airborne particulate matter and are considered to be causing serious health problems and environmental effects. They may nucleate as a result of combustion processes or result from photochemical reactions of volatile precursor gases, thus showing a clear link to gaseous pollution. Recently, direct emission of man-made nanoparticles, e.g. from the incineration or degradation of synthetic nanomaterials, has attracted considerable attention.
The scientific focus of the 2021 online meeting will be on interactions between air quality and the Corona pandemia, recent findings, hypothesis, monitoring results, health and impact assessments. Volatile particles and toxic effects, release of UFP e.g. by aircraft emissions, exposure assessment and the effect of lock-down episodes shall be treated.